2002
DOI: 10.1016/s0968-0896(02)00164-5
|View full text |Cite
|
Sign up to set email alerts
|

Chemopreventive potential of cyclic diarylheptanoids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
15
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 54 publications
(16 citation statements)
references
References 16 publications
1
15
0
Order By: Relevance
“…The in vitro inhibitory effects determined in the EBV-EA assay generally have been found to correlate well with in vivo inhibitory effects on tumor promotion as reported in many studies (Konoshima et al, 1994;Ishida et al, 2000Ishida et al, , 2002Sakurai et al, 2003;Wang et al, 2006). Therefore, based on the in vitro data, only three of the most potent compounds (13, 15, and 19) were examined in a two-stage in vivo skin carcinogenesis test evaluating mouse skin papilloma induced by DMBA as an initiator and TPA as a promoter (Table 2).…”
Section: In Vivo Mouse Skin Carcinogenesis Inhibitionsupporting
confidence: 68%
“…The in vitro inhibitory effects determined in the EBV-EA assay generally have been found to correlate well with in vivo inhibitory effects on tumor promotion as reported in many studies (Konoshima et al, 1994;Ishida et al, 2000Ishida et al, , 2002Sakurai et al, 2003;Wang et al, 2006). Therefore, based on the in vitro data, only three of the most potent compounds (13, 15, and 19) were examined in a two-stage in vivo skin carcinogenesis test evaluating mouse skin papilloma induced by DMBA as an initiator and TPA as a promoter (Table 2).…”
Section: In Vivo Mouse Skin Carcinogenesis Inhibitionsupporting
confidence: 68%
“…The test was performed as described earlier (Tokuda et al, 1998;Ishida et al, 2002). The animals (SPF female SENCAR mice, 6-weeks-old) were divided into three experimental groups of 15 mice each.…”
Section: Two-stage Mouse Skin Carcinogenesis Test Induced By Peroxynimentioning
confidence: 99%
“…However, to the best of our knowledge, the structure–activity relationship (SAR) study of cyclic diarylheptanoids is very limited [80,182,183]; thus, the identification of good drug candidates has not been fruitful yet. Not only development of a facile enantioselective macrocyclization method but also more intense SAR study have become a prerequisite for realizing such a goal.…”
Section: Discussionmentioning
confidence: 99%